Research progress of long noncoding RNAs in ocular proliferative diseases

Authors: Huang Xiaobo,  Zou Haidong

DOI: 10.3760/cma.j.issn.2095-0160.2017.12.017
Published 2017-12-10
Cite as Chin J Exp Ophthalmol, 2017,35(12): 1135-1138.

Abstract                                [Download PDF] [Read Full Text]

Ocular proliferative diseases, such as proliferative vitreous retinopathy (PVR), diabetic retinopathy (DR), choroidal neovascularization, corneal neovascularization and so on, often do harm to the structure and function of the eyes, and responses to treatments of late stage of these diseases are poor.Long noncoding RNAs (lncRNAs) with a length greater than 200 nucleotides can not directly encode a protein but can regulate the expression of protein coding genes through various pathways, and are widely involved in the regulation of body growth, as well as in cell apoptosis, proliferation and differentiation.More and more evidence suggests that lncRNAs are involved in the occurrence and development of a variety of ocular diseases.In the present paper, the concept, classification and mechanism of lncRNAs, and recent advances in the role of lncRNAs in PVR, DR, choroidal neovascularization and corneal neovascularization were reviewed.

Key words:

Proliferative vitreous retinopathy; Diabetic retinopathy; Choroidal neovascularization; Corneal neovascularization; Long noncoding RNA

Contributor Information

Huang Xiaobo
Department of Ophthalmology, Nantong First People’s Hospital, Nantong University, Nantong 226001, China
Zou Haidong
Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai Eye Disease Prevention & Treatment Center, Shanghai Eye Hospital, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai 200080, China
(Read 39 times, 1 visits today)
Updated: February 17, 2023 — 8:50 am